Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

One Health Approaches to Trace 's Zoonotic Potential Through Time.

Urban C, Blom A, Pfrengle S, et al. Frontiers in microbiology. 2021;
Download PDF
Publication

Host-Related Laboratory Parameters for Leprosy Reactions.

Luo Y, Kiriya M, Tanigawa K, et al. Frontiers in medicine. 2021;
Download PDF
Publication

Pure Neuritic Leprosy with Bilateral Foot Drop and Central Nervous Involvement: A Clinical, Electrophysiological, and MR Correlation.

Bhoi S, Naik S, Purkait S. Neurology India. 2021; 69 (5) : 1349-1353.
Download PDF
Publication

The expression of FOXP3 in lesions of several forms of leprosy in patients co-infected with HIV.

Xavier MB, Pires CAA, Gomes C, et al. PLoS neglected tropical diseases. 2021; 15 (11) : e0009887.
Download PDF
Publication

De Novo Histoid Leprosy With Unusual Histological Features.

Samiey F, Aljalahma J, Awadhi A. Cureus. 2021; 13 (11) : e19230.
Download PDF
Publication

Leprosy morbidity and mortality in Brazil: 2008-2018.

Miguel C, da Mota P, Afonso BO, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2021; 25 (6) : 101638.
Download PDF
Publication

Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study.

Chen X, Liu H, Shui T, et al. PLoS neglected tropical diseases. 2021; 15 (11) : e0009923.
Download PDF
Publication

Minimally invasive sampling to identify leprosy patients with a high bacterial burden in the Union of the Comoros.

Braet S, van Hooij A, Hasker EC, et al. PLoS neglected tropical diseases. 2021; 15 (11) : e0009924.
Download PDF
Publication

WHO Global Leprosy Update for 2020

ILEP Technical Commission . 2021;
Download PDF
Publication

Protagonismo de adolescentes na criação de um storyboard para um jogo digital sobre hanseníase

Santos TA, Araújo BDFPD, Neto WB, et al. Universidade Federal do Parana. Cogitare Enfermagem. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 237
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD